(Q40433269)

20 September 2017

1 reference

title

Can co-stimulated tumor immunity be therapeutically efficacious? (English)

1 reference

20 September 2017

Can Co‐stimulated Tumor Immunity be Therapeutically Efficacious? (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

30 May 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590823

30 May 2024

K. E. Hellström

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590823

30 May 2024

I. Hellström

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590823

30 May 2024

L. Chen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590823

30 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7590823

30 May 2024

publication date

1 June 1995

1 reference

full work available at URL

20 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-065X.1995.tb00079.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-065X.1995.tb00079.x

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

30 May 2024

published in

Immunological Reviews

1 reference

20 September 2017

volume

145

1 reference

20 September 2017

page(s)

123-145

1 reference

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

The CD28/B7 pathway costimulates the response of primary murine T cells to superantigens as well as to conventional antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Costimulation of T cells for tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Tumor-specific immune responses and opportunities for tumor vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Natural history of HLA expression during tumour development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Tolerogenicity of resting and activated B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Cytotoxic T Cells Isolated from Ovarian Malignant Ascites Recognize a Peptide Derived from the HER-2/neu Proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

The B7 and CD28 receptor families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Immunobiology of tissue transplantation: a return to the passenger leukocyte concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

CTLA-4 is a second receptor for the B cell activation antigen B7

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Heat-stable antigen is a costimulatory molecule for CD4 T cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Suppressor mechanisms in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Identification of human cancers deficient in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Acquisition of immunologic self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Rejection of B16 melanoma induced by expression of a transfected major histocompatibility complex class I gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

21 January 2018

A new look for the 1990s

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Source of unique tumour antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

ICAM-1 (CD54) expression on B lymphocytes is associated with their costimulatory function and can be increased by coactivation with IL-1 and IL-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00079.X

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/EJI.1830230929

Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen.

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Toward a genetic analysis of tumor rejection antigens.

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

A Theory of Self-Nonself Discrimination: Paralysis and induction involve the recognition of one and two determinants on an antigen, respectively

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Dose-dependent T cell tolerance to an immunodominant self peptide

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

"Natural" presentation of human papillomavirus type-16 E7 protein to immunocompetent mice results in antigen-specific sensitization or sustained unresponsiveness

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Activation of CD4+ T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation).

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Transfected mouse melanoma lines that express various levels of human melanoma-associated antigen p97

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Treatment of murine lupus with CTLA4Ig

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Cellular Immunity Against Tumor Antigens

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Evidence that tumor antigens enhance tumor growth in vivo by interacting with a radiosensitive (suppressor?) cell population

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Oncogene-associated tumor antigens as targets for immunotherapy

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Expression of the co-stimulatory molecule B7 on melanoma cells

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line.

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Further studies on isoantigenic variation in mouse carcinomas and sarcomas

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

The role of the CD28 receptor during T cell responses to antigen

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells.

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Tumor eradication by adoptive transfer of cytotoxic T lymphocytes

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Hepatitis B virus infection, the immune response and hepatocellular carcinoma

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

A mouse mutant p53 product recognized by CD4+ and CD8+ T cells

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papilloma virus E7 protein

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines

30 May 2024

105

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells

30 May 2024

107

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

30 May 2024

Tumor antigens

110

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

30 May 2024

111

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

CTLA4Ig treatment ameliorates the lethality of murine graft-versus-host disease across major histocompatibility complex barriers

30 May 2024

112

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes

30 May 2024

114

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes

30 May 2024

117

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

T and B cell tolerance and responses to viral antigens in transgenic mice: implications for the pathogenesis of autoimmune versus immunopathological disease

30 May 2024

119

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00079.X

30 May 2024

Identifiers

1 reference

20 September 2017

1 reference